We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The UK Health Security Agency (UKHSA) has today published updated guidance to support the next stage of the COVID-19 pandemic.
Information on who can access free coronavirus (COVID-19) tests from 1 April 2022 and how to get them.
The UK Health Security Agency (UKHSA) announces temporary changes to confirmatory PCR tests.
Findings from the final report of the government-backed REACT-1, one of the largest studies into coronavirus (COVID-19) infections in England, have been published today.
This new combination treatment is for people with mild to moderate COVID-19 who are at high risk of developing severe COVID-19
The antiviral was found to be safe and effective following a stringent review of the available evidence.…
Prescription charge waiver for COVID-19 antivirals and therapeutic clinical trials to be extended to 31 March 2023.
First published during the 2019 to 2022 Johnson Conservative government
A statement on prescription charges for COVID-19 antiviral medicines.
The public are being urged to sign up to a world-leading study for antivirals if they test positive for COVID-19.
Letter from Health Minister Maggie Throup confirming UK Health Security Agency’s role and priorities for the financial year 2022 to 2023.
The Antivirals Taskforce will identify treatments for UK patients who have been exposed to COVID-19 to stop the infection spreading and speed up recovery time.
The Secretary of State for Health and Social Care's letter to a group of charities and patients on the decision not to procure Evusheld as a COVID-19 treatment.
First published during the 2022 Truss Conservative government
The new antivirals could be rolled out through a clinical study from winter.
Thousands of vulnerable people are to receive cutting-edge antiviral and antibody treatments for coronavirus (COVID-19).
This week’s UKHSA surveillance data shows the sharpest weekly increase in flu activity so far this winter, signalling flu season is officially underway.
Thousands of those most at-risk to COVID-19 will soon be able to access the UK’s second ground-breaking antiviral
Over 5,000 people have now enrolled in a world-class study for COVID-19 antivirals, meaning thousands of people have accessed the medicines
Weekly national influenza and COVID-19 report, COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
Lynda Scammell, Senior Enforcement Advisor at the Medicines and Healthcare products Regulatory Agency (MHRA) today warned the public about medicines and other medical products being sold online claiming to treat or prevent COVID-19.…
The MHRA has published advice for patients and healthcare professionals
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).